Sarepta Therapeutics Statistics
Total Valuation
SRPT has a market cap or net worth of $1.73 billion. The enterprise value is $2.15 billion.
Important Dates
The last earnings date was Monday, November 3, 2025, after market close.
| Earnings Date | Nov 3, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
SRPT has 104.77 million shares outstanding. The number of shares has decreased by -2.62% in one year.
| Current Share Class | 104.77M |
| Shares Outstanding | 104.77M |
| Shares Change (YoY) | -2.62% |
| Shares Change (QoQ) | -5.99% |
| Owned by Insiders (%) | 4.70% |
| Owned by Institutions (%) | 76.84% |
| Float | 87.65M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 0.99 |
| Forward PS | 1.13 |
| PB Ratio | 1.94 |
| P/TBV Ratio | 1.32 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 0.89 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 2.95, with a Debt / Equity ratio of 0.95.
| Current Ratio | 2.95 |
| Quick Ratio | 1.35 |
| Debt / Equity | 0.95 |
| Debt / EBITDA | 14.35 |
| Debt / FCF | n/a |
| Interest Coverage | -4.68 |
Financial Efficiency
Return on equity (ROE) is -21.37% and return on invested capital (ROIC) is -2.06%.
| Return on Equity (ROE) | -21.37% |
| Return on Assets (ROA) | -1.52% |
| Return on Invested Capital (ROIC) | -2.06% |
| Return on Capital Employed (ROCE) | -3.34% |
| Revenue Per Employee | $1.76M |
| Profits Per Employee | -$197,897 |
| Employee Count | 1,372 |
| Asset Turnover | 0.68 |
| Inventory Turnover | 1.68 |
Taxes
In the past 12 months, SRPT has paid $19.33 million in taxes.
| Income Tax | 19.33M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -86.54% in the last 52 weeks. The beta is 0.52, so SRPT's price volatility has been lower than the market average.
| Beta (5Y) | 0.52 |
| 52-Week Price Change | -86.54% |
| 50-Day Moving Average | 20.33 |
| 200-Day Moving Average | 46.60 |
| Relative Strength Index (RSI) | 32.47 |
| Average Volume (20 Days) | 5,797,484 |
Short Selling Information
The latest short interest is 17.69 million, so 16.88% of the outstanding shares have been sold short.
| Short Interest | 17.69M |
| Short Previous Month | 19.62M |
| Short % of Shares Out | 16.88% |
| Short % of Float | 20.18% |
| Short Ratio (days to cover) | 2.84 |
Income Statement
In the last 12 months, SRPT had revenue of $2.41 billion and -$271.51 million in losses. Loss per share was -$2.77.
| Revenue | 2.41B |
| Gross Profit | 1.04B |
| Operating Income | -86.01M |
| Pretax Income | -252.19M |
| Net Income | -271.51M |
| EBITDA | -43.03M |
| EBIT | -86.01M |
| Loss Per Share | -$2.77 |
Full Income StatementBalance Sheet
The company has $850.99 million in cash and $1.25 billion in debt, giving a net cash position of -$399.20 million or -$3.81 per share.
| Cash & Cash Equivalents | 850.99M |
| Total Debt | 1.25B |
| Net Cash | -399.20M |
| Net Cash Per Share | -$3.81 |
| Equity (Book Value) | 1.32B |
| Book Value Per Share | 12.60 |
| Working Capital | 1.80B |
Full Balance SheetMargins
Gross margin is 42.92%, with operating and profit margins of -3.56% and -11.25%.
| Gross Margin | 42.92% |
| Operating Margin | -3.56% |
| Pretax Margin | -10.45% |
| Profit Margin | -11.25% |
| EBITDA Margin | -1.78% |
| EBIT Margin | -3.56% |
| FCF Margin | n/a |
Dividends & Yields
SRPT does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | 2.62% |
| Shareholder Yield | 2.62% |
| Earnings Yield | -15.53% |
| FCF Yield | n/a |
Dividend DetailsAnalyst Forecast
The average price target for SRPT is $35.85, which is 117.40% higher than the current price. The consensus rating is "Hold".
| Price Target | $35.85 |
| Price Target Difference | 117.40% |
| Analyst Consensus | Hold |
| Analyst Count | 30 |
| Revenue Growth Forecast (5Y) | -5.11% |
| EPS Growth Forecast (5Y) | 6.76% |
Stock ForecastsFair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
The last stock split was on July 12, 2012. It was a reverse split with a ratio of 1:6.
| Last Split Date | Jul 12, 2012 |
| Split Type | Reverse |
| Split Ratio | 1:6 |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 3 |
